miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.

International Journal of Oncology
You-Jie LiWei Chen

Abstract

MicroRNAs (miRNAs or miRs) have recently become a popular focus of cancer research due to their ability to act as oncogenes or tumor suppressors. In the present study, miR‑33a‑5p expression was identified to be downregulated in lung adenocarcinoma samples compared with normal, which suggested that miR‑33a‑5p may serve as a tumor suppressor gene. Transfection with miR‑33a‑5p mimics inhibited the proliferation and migration of A549 and LTEP‑a‑2 cells and increased cellular apoptosis. A luciferase reporter assay confirmed that miR‑33a‑5p targets the 3'‑untranslated region of the mechanistic target of rapamycin (mTOR) gene. mTOR expression was decreased in A549 and LTEP‑a‑2 cells treated with miR‑33a‑5p mimics, as well as the expression of its downstream effectors phosphorylated (p)‑p70 ribosomal protein S6 kinase (p70S6K) and p‑eukaryotic translation initiation factor 4E binding protein 1 (4EBP1). Following treatment with celastrol, miR‑33a‑5p expression was upregulated, and miR‑33a‑5p could enhance cellular sensitivity to celastrol. Western blot analysis revealed that the expression of mTOR, p‑p70S6K and p‑4EBP1 decreased following celastrol treatment. These results suggested that mTOR was involved in the mechanism by which miR‑3...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 22, 2003·The Journal of Biological Chemistry·Fatima LekmineLeonidas C Platanias
Nov 18, 2006·European Journal of Pharmacology·Xiaoxue ZhangYinye Wang
May 15, 2010·Science·S Hani Najafi-ShoushtariAnders M Näär
Dec 8, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Hee-Sun YangKwon-Il Seo
Aug 31, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Hangyu LiJingang Liu
Feb 11, 2014·International Journal of Cancer. Journal International Du Cancer·Xiaolan ZhuJian Wen
Aug 8, 2014·International Journal of Molecular Sciences·Longhe YangYan Qiu
Dec 17, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerMiranda Hughes
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Mar 30, 2016·Molecular BioSystems·Renping WangYunpeng Qi
Aug 10, 2016·Biochemical and Biophysical Research Communications·Jianquan GuoHuanjie Yang
Jun 1, 2017·Annals of Surgical Oncology·Kei AsukaiHideshi Ishii
Sep 28, 2017·Oncotarget·Omer Faruk KaratasMichael Ittmann

❮ Previous
Next ❯

Citations

Feb 13, 2019·Frontiers in Oncology·Li-Na XuXiao-Jian Yan
Dec 29, 2020·Frontiers in Pharmacology·Jinfeng ShiChaomei Fu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.